A study to evaluate the safety and tolerability of AZD7442 in Healthy Chinese Adults

Trial Identifier: D8850C00007
Sponsor: AstraZeneca
NCTID:: NCT05437289
Start Date: October 2021
Primary Completion Date: November 2021
Study Completion Date: January 2023
Condition: Healthy Volunteers

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
English Version
Simplified Chinese (China)

Trial Locations

Country Location
CN Guangzhou, CN, 510515
CN Shanghai, CN, 201107